Factors Affecting Immediate Anterior Implants Esthetics.
1 other identifier
observational
500
0 countries
N/A
Brief Summary
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 20, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
Study Completion
Last participant's last visit for all outcomes
September 1, 2026
April 22, 2026
April 1, 2026
2 months
April 13, 2026
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pink esthetic score
3 years
Study Arms (1)
IIP in anterior maxilla
Immediate implant placement from canine to canine
Eligibility Criteria
All patients were treated with flapless immediate implants with no grafting procedures in the esthetic zone.
You may qualify if:
- flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
- presence of immediate postoperative CBCT,
- initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
- thin intact labial bone plate (\< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
- patients who had provided an informed consent.
You may not qualify if:
- patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
- patients with active infection related at the site of implant and patients with untreated active periodontal diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director
Study Record Dates
First Submitted
April 13, 2026
First Posted
April 20, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share